How individuals with spinal cord injury in the United States access and assess information about experimental therapies and clinical trials: results of a clinical survey

被引:0
|
作者
Clara Farrehi
Carlotta Pazzi
Maclain Capron
Kim Anderson
Bonnie Richardson
Michael Stillman
机构
[1] Sidney Kimmel Medical College of Thomas Jefferson University,Metrohealth Medical Center
[2] Case Western Reserve University School of Medicine,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 31 条
  • [1] How individuals with spinal cord injury in the United States access and assess information about experimental therapies and clinical trials: results of a clinical survey
    Farrehi, Clara
    Pazzi, Carlotta
    Capron, Maclain
    Anderson, Kim
    Richardson, Bonnie
    Stillman, Michael
    SPINAL CORD SERIES AND CASES, 2020, 6 (01)
  • [2] GENERALIZABILITY OF THE CLINICAL TRIALS ON THERAPIES OF INDIVIDUALS WITH ACUTE TRAUMATIC SPINAL CORD INJURY
    Furlan, Julio C.
    Craven, B. Catharine
    JOURNAL OF NEUROTRAUMA, 2018, 35 (16) : A171 - A171
  • [3] Cell Therapies for Spinal Cord Injury: Trends and Challenges of Current Clinical Trials
    Bartlett, Richard D.
    Burley, Sarah
    Ip, Mina
    Phillips, James B.
    Choi, David
    NEUROSURGERY, 2020, 87 (04) : E456 - E472
  • [4] Improving access to clinical trials for people with spinal cord injury: The promise of SCI Trials Finder
    Murphy, Carolann
    Thomas, Florian P.
    JOURNAL OF SPINAL CORD MEDICINE, 2024, 47 (06): : 811 - 812
  • [5] Feasibility of patient recruitment into clinical trials of experimental treatments for acute spinal cord injury
    Lee, Robert S.
    Noonan, Vanessa K.
    Batke, Juliet
    Ghag, Arvindera
    Paquette, Scott J.
    Boyd, Michael C.
    Fisher, Charles G.
    Street, John
    Dvorak, Marcel F.
    Kwon, Brian K.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (10) : 1338 - 1343
  • [6] An Assessment of Which Sociodemographic and Spinal Cord Injury-Specific Characteristics Influence Engagement With Experimental Therapies and Participation in Clinical Trials
    Pazzi, Carlotta
    Farrehi, Clara
    Capron, Maclain
    Anderson, Kim
    Richardson, Bonnie
    Stillman, Michael
    TOPICS IN SPINAL CORD INJURY REHABILITATION, 2021, 27 (04) : 28 - 39
  • [7] Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?
    Wong, Raymond
    Hejrati, Nader
    Fehlings, Michael G. G.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (06) : 487 - 499
  • [8] Cell therapies for spinal cord injury: a review of the clinical trials and cell-type therapeutic potential
    Ribeiro, Beatriz F.
    da Cruz, Bruna C.
    de Sousa, Barbara M.
    Correia, Patricia D.
    David, Nuno
    Rocha, Camila
    de Almeida, Ramiro
    da Cunha, Maria Ribeiro
    Baptista, Antonio A. Marques
    Vieira, Sandra, I
    BRAIN, 2023, 146 (07) : 2672 - 2693
  • [9] Expectations of Benefit and Tolerance to Risk of Individuals with Spinal Cord Injury Regarding Potential Participation in Clinical Trials
    Kwon, Brian K.
    Ghag, Arvindera
    Dvorak, Marcel F.
    Tetzlaff, Wolfram
    Illes, Judy
    JOURNAL OF NEUROTRAUMA, 2012, 29 (18) : 2727 - 2737
  • [10] Importance of access to research information among individuals with spinal cord injury: results of an evidenced-based questionnaire
    Edwards, L
    Krassioukov, A
    Fehlings, MG
    SPINAL CORD, 2002, 40 (10) : 529 - 535